Copyright: ©Author(s) 2026.
Artif Intell Gastroenterol. Nov 8, 2026; 7(3): 125000
Published online Nov 8, 2026. doi: 10.35712/aig.125000
Published online Nov 8, 2026. doi: 10.35712/aig.125000
Figure 4 Key studied and emerging applications of artificial intelligence in pancreatic, biliary, and liver diseases: A conceptual summary.
Bold and italic text indicates artificial intelligence applications supported by the strongest available clinical evidence. MASLD: Metabolic dysfunction-associated steatotic liver disease; MASH: Metabolic dysfunction-associated steatohepatitis; HCC: Hepatocellular carcinoma; ERCP: Endoscopic retrograde cholangio pancreatography; EHR: Electronic health record; PDAC: Pancreatic ductal adenocarcinoma.
- Citation: Roy SK, Samanta A, Banerjee A. Artificial intelligence in gastroenterology practice: Current perspectives and emerging prospects. Artif Intell Gastroenterol 2026; 7(3): 125000
- URL: https://www.wjgnet.com/2644-3236/full/v7/i3/125000.htm
- DOI: https://dx.doi.org/10.35712/aig.125000